openPR Logo
Press release

Global Peptide Based Metabolic Disorders Therapeutics Market, Size, Share, Growth, Trends and Forecast 2017 - 2022.

02-21-2018 01:50 PM CET | Health & Medicine

Press release from: Fact.MR

Fact.MR

Fact.MR

Peptide therapeutics are used to treat metabolic disorders. The global peptide based metabolic disorders therapeutics market is impacted by aspects which link to the various benefits that peptides offer in treating ailments, to name a few, the government regulations to better the healthcare industry, the increasing foreign direct investments, the rising investments in healthcare, and the increasing bio-pharma companies. This Fact.MR report analyzes the expansion of global peptide based metabolic disorders therapeutics market till date, and provides key insights on the growth of the market during the forecast period, 2017-2022.

A metabolic disorder is a disorder which can occur due to alterations in the normal metabolic processes in the body caused by abnormal chemical reactions take place within. Peptide therapeutics are used to treat metabolic disorders owing to their stability, efficiency, safety as well as tolerability. Due to their broad range of mechanisms and activities, they can be used in the treatment of metabolic disorders.

Request For Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=187

According to Fact.MR’s research report on the global peptide based metabolic disorders therapeutics market, the market is anticipated to show a robust growth rate during the forecasted period of 2017-2022 and expected to reflect a value more than US$ 8 Bn.

Exenatide and Others Segments Have a Tie

The exenatide and others segments by drug class show similar growth rate and hence can be said to congruently move along during the period of forecast. However, the exenatide segment enjoys a higher market share than the others segment, more than three times than that of the others segment during 2017 and this trend is expected to run its course throughout the period of forecast. Both these segments are expected to show a gain in the BPS by the end of 2022.

Hospital Pharmacies Segment Shows Supremacy, Online Pharmacy Shows Growth

The hospital pharmacies segment by distribution channel reflect a higher market share by revenue and a higher growth rate throughout the period of forecast. However, the online pharmacies segment shows even higher growth rate as compared to hospital pharmacies segment, and is expected to register a CAGR of 11.8% during the period of forecast. But the market share of this segment is less; hospital pharmacies segment enjoys a market share more than three times than that of online pharmacies segment. The online pharmacies segment is expected to enjoy a gain in the BPS by the end of 2022. On the other hand, the retail pharmacies segment shows moderate growth rate, yet higher than that of the hospital pharmacies segment and a market share more than double than that of the online pharmacies segment as of 2017.

Competition Tracking

The report also profiles companies that are expected to remain active in the expansion of the global peptide based metabolic disorders therapeutics market through 2022, which include AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., PolyPeptide Group, Novo Nordisk A/S, Merck & Co., Inc., Ipsen S.A, Eli Lilly and Company, CordenPharma International, and Bachem Holding AG.

Browse Full Report With TOC- https://www.factmr.com/report/187/peptide-based-metabolic-disorders-therapeutics-market

Table of Content

Global Peptide Based Metabolic Disorders Therapeutics Market - Executive Summary
Global Peptide Based Metabolic Disorders Therapeutics Market Overview
2.1. Introduction
       2.1.1. Global Peptide Based Metabolic Disorders Therapeutics Market Taxonomy
       2.1.2. Global Peptide Based Metabolic Disorders Therapeutics Market Definition
2.2. Global Peptide Based Metabolic Disorders Therapeutics Market Size (US$ Mn) and Forecast, 2012-2022
       2.2.1. Global Peptide Based Metabolic Disorders Therapeutics Market Y-o-Y Growth
2.3. Global Peptide Based Metabolic Disorders Therapeutics Market Dynamics
2.4. Regulations
2.5. Supply Chain
2.6. Cost Structure
2.7. Average Pricing Analysis 
2.8. Epidemiology
2.9. Key Participants Market Presence (Intensity Map) By Region
Global Peptide Based Metabolic Disorders Therapeutics Market Analysis and Forecast By Drug 
3.1. Global Peptide Based Metabolic Disorders Therapeutics Market Size and Forecast By Drug, 2012-2022
       3.1.1. Liraglutide Peptide Based Metabolic Disorders Therapeutics Market Size and Forecast, 2012-2022
                3.1.1.1. Revenue (US$ Mn) Comparison, By Region
                3.1.1.2. Market Share Comparison, By Region
                3.1.1.3. Y-o-Y growth Comparison, By Region
       3.1.2. Exenatide Peptide Based Metabolic Disorders Therapeutics Market Size and Forecast, 2012-2022
                3.1.2.1. Revenue (US$ Mn) Comparison, By Region
                3.1.2.2. Market Share Comparison, By Region
                3.1.2.3. Y-o-Y growth Comparison, By Region
       3.1.3. Others Peptide Based Metabolic Disorders Therapeutics Market Size and Forecast, 2012-2022
                3.1.3.1. Revenue (US$ Mn) Comparison, By Region
                3.1.3.2. Market Share Comparison, By Region
                3.1.3.3. Y-o-Y growth Comparison, By Region
Continue…..

Request For Discount On This Report- https://www.factmr.com/connectus/sample?flag=D&rep_id=187

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Telephone: +353-1-6111-593
Email: sales@factmr.com/
Web: https://www.factmr.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Peptide Based Metabolic Disorders Therapeutics Market, Size, Share, Growth, Trends and Forecast 2017 - 2022. here

News-ID: 952296 • Views: 170

More Releases from Fact.MR

Future Trends in the Automotive Lift Market | AE Automotive Equipment Co. Ltd., …
The automotive lifts industry is projected to rise at a steady CAGR of 4.2% between 2019 and 2026. High component replacement rates, and expensive costs of labor and spare parts remain the primary factors driving sales of automotive lifts. Convenient operation and growing prominence of workplace safety will continue to aid the growth of the automotive lifts market, reveals Fact.MR in its new study. "Rapid growth in vehicle sales volume will
Seed Drill Machines Market Worth US$ 620 Mn by 2026 | KUBOTA Corporation, Mahi …
Fact.mr has published a latest research report on the Seed Drill Machines market. The key object of this report is to offer detailed analysis of key factors supporting the growth of the market for Seed Drill Machines. Besides, it covers technological advancements, demand statistics, growth dynamics, and regional analysis of the market during the historical period of 2012 – 2016. The Seed Drill Machines market report is intended to offer all the important information
Wear Resistant Steel Plate Market: New Fact.MR Study Offers Insights for 2019 t …
Fact.MR has come up with a study on Wear Resistant Steel Plate Market and the report is laden with information that can be utilized by stakeholders in the market to make informed decisions. Analysts have widely utilized the well-entrenched and effective market intelligence tools to collect and collate and then present the analysis and assessment of the Wear Resistant Steel Plate Market in an easily understandable format for all. The report
Methyl Tertiary-Butyl Ether Market Analyzed to 2026 | Petronas Chemicals Group …
A new study on the Methyl Tertiary-Butyl Ether market provides a detailed overview of the demands and consumptions of various products/services associated with the growth dynamics of the market .The in-depth market estimation of various opportunities in the segments is expressed in volumes and revenues during the forecast period 2017 to 2026. The insights and analytics on the Future of the Methyl Tertiary-Butyl Ether market span several pages. These are covered in numerous

All 5 Releases


More Releases for Peptide

Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established
Peptide Therapeutics Market | Forecast up to 2024
Global Peptide Therapeutics Market: Overview This report provides in-depth region wise and country wise analysis of the peptide therapeutics market. Stakeholders of this report include manufacturers of peptide products, raw material suppliers, nutraceutical and cosmeceutical companies, food processing industries and new players planning to enter the market. It further provides qualitative and quantitative analysis of the global peptide therapeutics market. Qualitative analysis comprises market dynamics, trends, product overview, and country-level market
Peptide Vaccine Market Peptide Vaccine Clinical Pipeline Report 2020
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Peptide Vaccine: A Prologue to Sub-Unit Vaccines 1.1 Introduction 1.2 Glimpse of Antiquity 2. Need of Peptide Vaccines 2.1 Why Peptides – More Desirable 2.2 Peptide Vaccines V/S Traditional Vaccines 3. Classification of Peptide Vaccines 3.1 On the Basis of Sources Obtained 3.2 On the Basis of Length 3.3 On the Basis of
Global Natriuretic Peptide Market Research Report 2017
Report Hive Market Research Released a New Research Report of 107 pages on Title " Global Natriuretic Peptide Market Research Report 2017 "with detailed Analysis, Forecast and Strategies. In this report, the global Natriuretic Peptide market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented
Global Peptide Therapeutics Pipeline Insight 2015
Peptides are small molecules of varying molecular masses that consist of amino acids joined with the help of peptide bonds (CONH2). One end of the molecule consists of carboxyl (COOH2) group while the other end has amino (NH2) group giving rise to polarity. Biologically, they are very important and found to play an important role in various anabolic and catabolic processes. They are essential component of cell signaling pathways, immune
Global Peptide Vaccine Market & Pipeline Insight
Peptide vaccines are peptides that exhibit pharmacological properties by activating human immune system rather than showing pharmacologically activity by themselves. They are administered into body to enter in lymph nodes where they induce long lasting immune response. They utilize immune system and develop long term acquired immunity which has capability to prevent future incidences of pathogen attack. Every living cell in human body has surface markers as an instrument to